Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRN1005 alone or with Trastuzumab in breast cancer brain metastases
NCT01480583Phase 2Completed
- Sponsor
- Angiochem Inc.
- Start
- Oct 2011
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel trevatide in breast cancer, sponsored by Angiochem Inc.. Started Oct 2011; status: completed.
02
Drugs
paclitaxel trevatide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01480583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480583.